Cargando…

New MT(2) Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists

The search for melatonin receptor agonists and antagonists specific towards one of the receptor subtypes will extend our understanding of the role of this system in relaying circadian information to the body. A series of compounds derived from a hit compound discovered in a screening process led to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boutin, Jean A., Bonnaud, Anne, Brasseur, Chantal, Bruno, Olivier, Lepretre, Nolwenn, Oosting, Peter, Coumailleau, Sophie, Delagrange, Philippe, Nosjean, Olivier, Legros, Céline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535840/ https://www.ncbi.nlm.nih.gov/pubmed/28644418 http://dx.doi.org/10.3390/ijms18071347

Ejemplares similares

Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT(1) and MT(2) receptors
por: Legros, Céline, et al.
Publicado: (2019)

Hamster Melatonin Receptors: Cloning and Binding Characterization of MT(1) and Attempt to Clone MT(2)
por: Gautier, Célia, et al.
Publicado: (2018)

Recombinant Human Melatonin Receptor MT1 Isolated in Mixed Detergents Shows Pharmacology Similar to That in Mammalian Cell Membranes
por: Logez, Christel, et al.
Publicado: (2014)

New Radioligands for Describing the Molecular Pharmacology of MT(1) and MT(2) Melatonin Receptors
por: Legros, Céline, et al.
Publicado: (2013)

Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors hMT1 and hMT2
por: Cantarini, Mattia, et al.
Publicado: (2023)

PT628. First in class melatonin MT2 receptors agonists for neuropathic pain
por: Gobbi, Gabriella, et al.
Publicado: (2016)

The five dimensions of receptor pharmacology exemplified by melatonin receptors: An opinion
por: Boutin, Jean A., et al.
Publicado: (2019)

Sleep-promoting action of IIK7, a selective MT(2) melatonin receptor agonist in the rat
por: Fisher, Simon P., et al.
Publicado: (2009)

The Efficiency of CD4 Recruitment to Ligand-engaged TCR Controls the Agonist/Partial Agonist Properties of Peptide–MHC Molecule Ligands
por: Madrenas, Joaquín, et al.
Publicado: (1997)

Mood Disorders, Circadian Rhythms, Melatonin and Melatonin Agonists
por: Quera Salva, M.A., et al.
Publicado: (2012)

New Quinoxaline Derivatives as Potential MT(1) and MT(2) Receptor Ligands
por: Ancizu, Saioa, et al.
Publicado: (2012)

The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species
por: Stroethoff, Martin, et al.
Publicado: (2020)

Dissociation of Intracellular Signaling Pathways in Response to Partial Agonist Ligands of the T Cell Receptor
por: Chau, Luan A., et al.
Publicado: (1998)

Characterization of the Mel1c melatoninergic receptor in platypus (Ornithorhynchus anatinus)
por: Gautier, Célia, et al.
Publicado: (2018)

Pistacia vera Extract Potentiates the Effect of Melatonin on Human Melatonin MT(1) and MT(2) Receptors with Functional Selectivity
por: Labani, Nedjma, et al.
Publicado: (2023)

Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist
por: Wang, Yu-Hua, et al.
Publicado: (2018)

Structural basis for ligand recognition at the human MT(1) melatonin receptor
por: Stauch, Benjamin, et al.
Publicado: (2019)

Melatonin and Melatonin Agonists for Prevention of Delirium in the Cardiac Surgical ICU: A Meta-analysis
por: Niyogi, Subhrashis Guha, et al.
Publicado: (2023)

GW117: A novel serotonin (5‐HT(2C)) receptor antagonist and melatonin (MT(1)/MT(2)) receptor agonist with potential antidepressant‐like activity in rodents
por: Gao, Nana, et al.
Publicado: (2021)

The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor
por: Warne, Tony, et al.
Publicado: (2011)

Melatonin MT2 receptor agonist IIK-7 produces antinociception by modulation of ROS and suppression of spinal microglial activation in neuropathic pain rats
por: Kuthati, Yaswanth, et al.
Publicado: (2019)

Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders
por: Laudon, Moshe, et al.
Publicado: (2014)

Melatonin Receptors Agonistic Activities of Phenols from Gastrodia elata
por: Chen, Si-Yue, et al.
Publicado: (2019)

Structure-based discovery of potent and selective melatonin receptor agonists
por: Patel, Nilkanth, et al.
Publicado: (2020)

Mammalian Melatonin Agonist Pharmaceuticals Stimulate Rhomboid Proteins in Plants
por: Erland, Lauren A. E., et al.
Publicado: (2022)

Molecular dynamics of the ERRγ ligand-binding domain bound with agonist and inverse agonist
por: Sasidharan, Santanu, et al.
Publicado: (2023)

Melatonin and melatonin agonists to prevent and treat delirium in critical illness: a systematic review protocol
por: Foster, Jennifer, et al.
Publicado: (2016)

The genomic response of human granulosa cells (KGN) to melatonin and specific agonists/antagonists to the melatonin receptors
por: Arjoune, Asma, et al.
Publicado: (2022)

Theory of partial agonist activity of steroid hormones
por: Chow, Carson C., et al.
Publicado: (2015)

Nicotine receptor partial agonists for smoking cessation
por: Livingstone-Banks, Jonathan, et al.
Publicado: (2023)

Nicotine receptor partial agonists for smoking cessation
por: Livingstone-Banks, Jonathan, et al.
Publicado: (2023)

Synthetic partial agonists reveal key steps in IP(3) receptor activation
por: Rossi, Ana M., et al.
Publicado: (2009)

Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010)

Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19
por: Hooper, Philip L.
Publicado: (2021)

Protective effects of melatonin receptor agonists on endotoxin-induced uveitis in rats
por: Yuksel, Tugba Nurcan, et al.
Publicado: (2023)

Partial Agonist Activity of Neonicotinoids on Rat Nicotinic Receptors: Consequences over Epinephrine Secretion and In Vivo Blood Pressure
por: Park, Joohee, et al.
Publicado: (2021)

Phytoestrogens are partial estrogen agonists in the adult male mouse.
por: Mäkelä, S, et al.
Publicado: (1995)

Role of nicotine receptor partial agonists in tobacco cessation
por: Maity, Nivedita, et al.
Publicado: (2014)

Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia
por: Peris, Lola, et al.
Publicado: (2021)

Generalized Concentration Addition Predicts Joint Effects of Aryl Hydrocarbon Receptor Agonists with Partial Agonists and Competitive Antagonists
por: Howard, Gregory J., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2pkunp30vp47jhfvqctth0pcst